DANBURY, Conn.--(BUSINESS WIRE)--Praxair, Inc. (NYSE: PX) has priced $500 million of 3.00% notes due September 1, 2021. The notes are being offered under its universal shelf registration statement filed with the U.S. Securities and Exchange Commission. The offering is led by Credit Suisse Securities (USA) LLC, RBS Securities Inc., Mitsubishi UFJ Securities (USA), Inc., and Wells Fargo Securities, LLC.
The offering is expected to close on September 6, 2011. The company anticipates using the proceeds of the offering to repay short-term debt, to fund share repurchases under the company’s share repurchase program and for general corporate purposes. Prior to their application, the net proceeds may be invested in short-term investments. The company’s long-term debt is rated A2 by Moody’s Investors Service and A by Standard and Poor’s, a division of The McGraw-Hill Companies.
Nothing herein shall constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful. The offering is being made by means of a prospectus and related prospectus supplement only, copies of which or information concerning this offering may be obtained by contacting Credit Suisse Securities (USA) LLC at Eleven Madison Avenue, New York, NY 10010, 1-800-221-1037, Attention: Prospectus Department or RBS Securities Inc. at 600 Washington Blvd., Stamford, CT 06901, 1-866-884-2071, Attention: Debt Capital Markets Syndicate.
Praxair is the largest industrial gases company in North and South America, and one of the largest worldwide, with 2010 sales of $10.1 billion. The company produces, sells and distributes atmospheric and process gases, and high-performance surface coatings. Praxair’s products, services and technology bring productivity and environmental benefits to a wide variety of industries, including aerospace, chemicals, electronics, energy, food and beverage, healthcare, manufacturing, metals and others. More information on Praxair is available at www.praxair.com.